SEP 4, 2026 · PHASE 2/3 TRIAL
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
ClinicalTrials.gov
This is a Phase 2/3 registry record of an active trial with no reported results; the study is designed to evaluate antibody persistence to a novel GBS vaccine in pregnant women but has not yet yielded outcome data.
Reported
Planned enrollment137
Study phasePhase 2/3
Primary outcome measureConcentration of IgG Antibodies to AlpN Pro…